SEARCH

SEARCH BY CITATION

References

  • Arrabal L, Teresa L, Sanchez-Alcudia R, Castro M, Medrano C, Gutierrez-Solana L, Roldan S, Ormazabal A, Perez-Cerda C, Merinero B, Perez B, Artuch R, Ugarte M, Desviat LR. (2011) Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant. Neurogenetics 12:183191.
  • Bankier A, Turner M, Hopkins IJ. (1983) Pyridoxine dependent seizures–a wider clinical spectrum. Arch Dis Child 58:415418.
  • Baxter P. (2001) Pyridoxine-dependent and pyridoxine-responsive seizures. Dev Med Child Neurol 43:416420.
  • Bennett CL, Chen Y, Hahn S, Glass IA, Gospe SM Jr. (2009) Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients. Epilepsia 50:11671175.
  • Bok LA, Halbertsma FJ, Houterman S, Wevers RA, Vreeswijk C, Jakobs C, Struys E, JH VDH, Sival DA, Willemsen MA. (2012) Long-term outcome in pyridoxine-dependent epilepsy. Dev Med Child Neurol 54:849854.
  • Chou ML, Wang HS, Hung PC, Sun PC, Huang SC. (1995) Late-onset pyridoxine-dependent seizures: report of two cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 36:434437.
  • Coker SB. (1992) Postneonatal vitamin B6-dependent epilepsy. Pediatrics 90:221223.
  • Gospe SM. (2002) Pyridoxine-dependent seizures: findings from recent studies pose new questions. Pediatr Neurol 26:181185.
  • Goutieres F, Aicardi J. (1985) Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol 17:117120.
  • Hyland K, Arnold LA. (2002) Value of lumbar puncture in the diagnosis of infantile epilepsy and folinic acid-responsive seizures. J Child Neurol 17(Suppl. 3):3S483S55; discussion 43S56.
  • Kluger G, Blank R, Paul K, Paschke E, Jansen E, Jakobs C, Worle H, Plecko B. (2008) Pyridoxine-dependent epilepsy: normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness. Neuropediatrics 39:276279.
  • Milh M, Pop A, Kanhai W, Villeneuve N, Cano A, Struys EA, Salomons GS, Chabrol B, Jakobs C. (2007) Atypical pyridoxine-dependent epilepsy due to a pseudoexon in ALDH7A1. Mol Genet Metab 105:684686.
  • Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, Willemsen MA, Omran H, Tacke U, Uhlenberg B, Weschke B, Clayton PT. (2006) Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat Med 12:307309.
  • Mills PB, Footitt EJ, Mills KA, Tuschl K, Aylett S, Varadkar S, Hemingway C, Marlow N, Rennie J, Baxter P, Dulac O, Nabbout R, Craigen WJ, Schmitt B, Feillet F, Christensen E, De Lonlay P, Pike MG, Hughes MI, Struys EA, Jakobs C, Zuberi SM, Clayton PT. (2010) Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency). Brain 133:21482159.
  • Ormazabal A, Garcia-Cazorla A, Fernandez Y, Fernandez-Alvarez E, Campistol J, Artuch R. (2005) HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins. J Neurosci Methods 142:153158.
  • Perez B, Rodriguez-Pascau L, Vilageliu L, Grinberg D, Ugarte M, Desviat LR. (2010) Present and future of antisense therapy for splicing modulation in inherited metabolic disease. J Inherit Metab Dis 33:397403.
  • Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys E, Jakobs C, Hartmann H, Luecke T, Di Capua M, Korenke C, Hikel C, Reutershahn E, Freilinger M, Baumeister F, Bosch F, Erwa W. (2007) Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat 28:1926.
  • Richard E, Alvarez-Barrientos A, Perez B, Desviat LR, Ugarte M. (2007) Methylmalonic acidaemia leads to increased production of reactive oxygen species and induction of apoptosis through the mitochondrial/caspase pathway. J Pathol 213:453461.
  • Rincon A, Aguado C, Desviat LR, Sanchez-Alcudia R, Ugarte M, Perez B. (2007) Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA. Am J Hum Genet 81:12621270.
  • Salomons GS, Bok LA, Struys EA, Pope LL, Darmin PS, Mills PB, Clayton PT, Willemsen MA, Jakobs C. (2007) An intriguing “silent” mutation and a founder effect in antiquitin (ALDH7A1). Ann Neurol 62:414418.
  • Scharer G, Brocker C, Vasiliou V, Creadon-Swindell G, Gallagher RC, Spector E, Van Hove JL. (2010) The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1. J Inherit Metab Dis 33:571581.
  • Shin YS, Rasshofer R, Endres W. (1984) Pyridoxal-5′-phosphate concentration as marker for vitamin-B6-dependent seizures in the newborn. Lancet 2:870871.
  • Stockler S, Plecko B, Gospe SM Jr., Coulter-Mackie M, Connolly M, Van Karnebeek C, Mercimek-Mahmutoglu S, Hartmann H, Scharer G, Struijs E, Tein I, Jakobs C, Clayton P, Van Hove JL. (2011) Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab 104:4860.
  • Wolf NI, Bast T, Surtees R. (2005) Epilepsy in inborn errors of metabolism. Epileptic Disord 7:6781.
  • Wong JW, Chan CL, Tang WK, Cheng CH, Fong WP. (2010) Is antiquitin a mitochondrial enzyme? J Cell Biochem 109:7481.
  • Yeghiazaryan NS, Striano P, Spaccini L, Pezzella M, Cassandrini D, Zara F, Mastrangelo M. (2011) Long-term follow-up in two siblings with pyridoxine-dependent seizures associated with a novel ALDH7A1 mutation. Eur J Paediatr Neurol 15:547550.